drugset / Trial / NCT03803475
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
NaSingle-groupOpen-labelDiagnostic
Summary
The investigators are imaging patients with prostate cancer using a new Positron Emission Tomography (PET) imaging agent (Ga-68-PSMA-11) in order to evaluate its ability to detect prostate cancer.
Timeline
- Start
- 2018-10-11
- Primary completion
- 2020-08-25
- Completion
- 2020-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-PSMA-11 | Diagnostic / imaging agent | 3 unknown | Intravenous |
| Subject | 68Ga-PSMA-11 | Diagnostic / imaging agent | 7 unknown | Intravenous |